The National Diabetes Insulin Pump Audit is part of the National Diabetes Audit (NDA). The National Diabetes Insulin Pump Audit collects information on the number and characteristics of people with Type 1 diabetes using an insulin pump, the reasons for going on an insulin pump and the outcomes achieved since starting on the pump. Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. What information is being made available? National Diabetes Insulin Pump Audit data for 2017-18 is available at England and Wales, Local Health Board (LHB) and Specialist Diabetes Service level for:

The National Diabetes Audit (NDA) is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP) which is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England. The NDA is managed by NHS Digital in partnership with Diabetes UK. The NDA measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. The NDA collects and analyses data for use by a range of stakeholders to drive changes and improvements in the quality of services and health outcomes for people with diabetes. This report details the findings for the 2017-18 audit. The audit collected data during May and June 2018, for the period 01 January 2017 to 31 March 2018 and contains the full key findings, recommendations and new analysis relating to cardiovascular disease (CVD) risk, including new treatment targets showing statin prescriptions for CVD risk reduction. This report follows the NDA short report publication in November 2018, which provided the top level findings for the 2017-18 audit, along with local level data made available to services in a timely manner that can help drive improvements in the quality of diabetes care locally.

The information available from this webpage comes from the National Diabetes Audit - Diabetes Prevention Programme report.

The NHS Diabetes Prevention Programme (NHS DPP) is a joint commitment from NHS England, Public Health England and Diabetes UK to deliver, at scale, evidence based behavioural interventions that can prevent or delay the onset of Type 2 diabetes in adults who have been identified as having non-diabetic hyperglycaemia.

This report uses data collected alongside the National Diabetes Audit (NDA) for the period January 2017 to March 2018 inclusive.

This report is for England only. Unlike the NDA, it does not include information on Wales.

Making clinical audit data transparent

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

What information is being made available?

National Diabetes Audit - Diabetes Prevention Programme data for 2017-18 is available at England, Clinical Commissioning Group (CCG) and GP practice-level for:

• Patient list size
• Patient demographics
• Diabetes characteristics
• Diabetes Prevention Programme take-up

These data do not list individual patient information nor do they contain any patient identifiable data.

Using and interpreting the data

Data from the National Diabetes Audit - Diabetes Prevention Programme should not be looked at in isolation when assessing standards of care.

Accessing the data

The data are being made available on the data.gov website. Each year a data file from the National Diabetes Audit - Diabetes Prevention Programme will be made available in CSV format. Hospitals are identified by name and their national code.

What does the data cover?

The audit looks at the following areas:

• Registrations and prevalence
• Offers of DPP
• Demographics

What period does the data cover?

This report covers data collected alongside the National Diabetes Audit (NDA) for the period January 2017 to March 2018 inclusive. The audit report was published on 11 July 2019.

The National Diabetes Audit (NDA) provides a comprehensive view of diabetes care in England and Wales and measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards. Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. What information is being made available? National Diabetes Audit data for 2017-18 is available at England and Wales, Clinical Commissioning Group (CCG), Local Health Board (LHB), English GP practice and Specialist Diabetes Service level for: * Participation * Patient demographics * Diabetes characteristics * Structured Education offers These data do not list individual patient information nor do they contain any patient identifiable data. Using and interpreting the data Data from the National Diabetes Audit should not be looked at in isolation when assessing standards of care. Accessing the data The data are being made available on the data.gov website. GP practices and CCGs/LHBs are identified by organisation code. What does the data cover? The audit looks at the following areas: * Care processes * Treatment targets * Structured Education What period does the data cover? This data covers the top level findings from the 2017-18 National Diabetes Audit for the period 1 January 2017 to 31 March 2018. This National Report was published on 13 June 2019.

The National Diabetes Insulin Pump Audit is part of the National Diabetes Audit (NDA).

The National Diabetes Insulin Pump Audit collects information on the number and characteristics of people with Type 1 diabetes using an insulin pump, the reasons for going on an insulin pump and the outcomes achieved since starting on the pump.

Making clinical audit data transparent

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

What information is being made available?

National Diabetes Insulin Pump Audit data for 2016-17 is available at England and Wales, Local Health Board (LHB) and Specialist Diabetes Service level for:

• Participation
• Patient demographics
• Prevalence
• Care process completion
• Treatment targets
• Diabetes characteristics

Using and interpreting the data

Data from the National Diabetes Insulin Pump Audit should not be looked at in isolation when assessing standards of care.

Accessing the data

The data are being made available on the data.gov website. Local Health Boards and Specialist Diabetes Services are identified by organisation code.

What does the data cover?

The audit looks at the following areas:

• Reason for starting on an insulin pump
• Care processes
• Treatment targets
• Structured Education

What period does the data cover?

This data covers the top level findings from the 2016-17 National Diabetes Insulin Pump Audit for the period 1 January 2016 to 31 March 2017. This National Report was published on 14 June 2018.

The National Diabetes Inpatient Audit (NaDIA) measures the quality of diabetes care provided to people with diabetes while they are admitted to hospital whatever the cause, and aims to support quality improvement. Data is collected and submitted by hospital staff in England and Wales. The NaDIA audit is part of the National Diabetes Audit (NDA) portfolio within the National Clinical Audit and Patient Outcomes Programme (NCAPOP), commissioned by the Healthcare Quality Improvement Partnership (HQIP). The audit sets out to measure the quality of diabetes care provided to people with diabetes while they are admitted to hospital, by answering the following questions: Did diabetes management minimise the risk of avoidable complications? Did harm result from the inpatient stay? Was patient experience of the inpatient stay favourable? Has the quality of care and patient feedback changed since NaDIA 2010, 2011, 2012, 2013, 2015 and 2016?

It was estimated that as of 2023, around **** million people in the United States had been diagnosed with diabetes. The number of people diagnosed with diabetes in the U.S. has increased in recent years and the disease is now a major health issue. Diabetes is now the seventh leading cause of death in the United States, accounting for ******percent of all deaths. What is prediabetes? A person is considered to have prediabetes if their blood sugar levels are higher than normal but not high enough to be diagnosed with type 2 diabetes. As of 2021, it was estimated that around ** million men and ** million women in the United States had prediabetes. However, according to the CDC, around ** percent of these people do not know they have this condition. Not only does prediabetes increase the risk of developing type 2 diabetes, but also increases the risk of heart disease and stroke. The states with the highest share of adults who had ever been told they have prediabetes are California, Hawaii, and New Mexico. The prevalence of diabetes in the United States As of 2023, around *** percent of adults in the United States had been diagnosed with diabetes, an increase from ****percent in the year 2000. Diabetes is much more common among older adults, with around ** percent of those aged 60 years and older diagnosed with diabetes, compared to just ****percent of those aged 20 to 39 years. The states with the highest prevalence of diabetes among adults are West Virginia, Mississippi, and Louisiana, while Utah and Colorado report the lowest rates. In West Virginia, around ** percent of adults have been diagnosed with diabetes.

The National Diabetes Audit (NDA) is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP) which is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England and the Welsh Government. The NDA is managed by NHS Digital in partnership with Diabetes UK. The NDA measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. The NDA collects and analyses data for use by a range of stakeholders to drive changes and improvements in the quality of services and health outcomes for people with diabetes. This short report details the top-level findings for the 2018-19 audit. The audit collected data during May and June 2019, for the period 01 January 2018 to 31 March 2019. The top-level findings below, along with supporting data at Clinical Commissioning Group (CCG), Local Health Board (LHB), GP practice and specialist diabetes service have been made available to provide data back to services in a timely manner that can help drive improvements in the quality of diabetes care locally. The full report, scheduled for 2020, will contain full key findings, recommendations and results of new analyses into HbA1c check frequencies and blood glucose drug cohorts. We will communicate to users when the date for this report has been finalised. A new method of collecting structured education attendance data was trialled for 2018-19. In addition to extracting education data from GP practice systems, structured education providers could submit data directly via the Clinical Audit Platform (CAP). Around 20 providers submitted, however only a small proportion of records were submitted with the required data. This exercise has shown the potential value of this additional collection and improvements to the process are being developed to improve future collections.

The National Diabetes Audit (NDA) continues to provide a comprehensive view of Diabetes Care in England and Wales and measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. This national report presents the key findings and recommendations on care processes and treatment target achievement rates from 2015-2016 in all age groups in England and Wales along with information on offers and attendance for structured education places. This year, for the first time information is reported on the number of people with diabetes who also have a learning disability and completion of care processes and treatment target achievement. A separate national report presents the key findings and recommendations; The Learning Disability - Supplementary Information report has also been developed as a power point presentation. As with last year's publication the main report contains information on the national key findings and recommendations and has also been developed as a power point presentation, along with slides highlighting the national findings there is also space to allow the incorporation of locally produced slides using the tables and charts from the interactive spreadsheets. We hope that users will find this beneficial to help disseminate the results of the audit locally. Supplementary data for England and Wales are contained in the excel spreadsheets. There are 6 excel spreadsheets; two spreadsheets contains the tables and charts in the national report and learning disability report along with some supplementary national figures, a further spreadsheet provides all 8 care process completion and all 3 treatment target achievement for CCGs/LHBs by age group. There are also 3 interactive excel spreadsheets which allow users to select the CCG/GP practice (England only), Local Health Board (Wales only) or Secondary Care Service (England only) of choice, information for the chosen site is then displayed in tables and charts. Please note that the interactive excel spreadsheets are large files (approximately 12MB) and may take some time to open. This report was updated on 09/02/17. The following amendments have been made to the report: The CCG/GP spreadsheet was updated as some of the CCGs/general practices were not available in the interactive aspect. We have also added a reference table for practice codes and names. All the data for care processes and treatment targets was correct in the supporting data tables. The spreadsheet report for Wales and LHBs has been amended. A practice wrongly appeared in a LHB, this practice has now been assigned to the correct LHB which has changed the results for LHB 7A2 and 7A3. The specialist service spreadsheet has been updated as the interactive aspect was not working for all hospitals. This does not change the results for specialist services. Both the CCG/GP and LHB spreadsheets have been updated for structured education offered and attendance. This has changed the results for individual CCGs/Practices and LHBs but not the national results. We have updated the methodology documentation for structured education to explain more fully how we have analysed and reported on the structured education data for the 2015-16 audit report. We have also added a link, which can be found below in resources, to our interactive dashboard for the 2015-16 report. This dashboard provides CCGs, LHBs and GPs (England only) with an alternative way to view their data for completion of all 8 care process and achievement of all 3 treatment targets as well their data on registrations by age, sex, deprivation and ethnicity.

The National Diabetes Audit (NDA) provides a comprehensive view of diabetes care in England and Wales. It measures the effectiveness of diabetes healthcare against National Institute for Health and Care Excellence (NICE) Clinical Guidelines and NICE Quality Standards. This NICE guidance is based on evidence that regular systematic review of people with diabetes and achievement of glucose, blood pressure and cardiovascular risk standards maintains health and reduces long term complications.

The National Diabetes Transition Audit (NDTA) is a joint enterprise between the National Diabetes Audit (NDA) and the National Paediatric Diabetes Audit (NPDA) measuring the care of young people with diabetes during the transition from paediatric diabetes services to adult diabetes services.

This is the second published report for the NDTA and contains linked data from the NPDA and NDA for the audit period 2011-12 to 2016-17. The report focuses on young people with Type 1 diabetes.

Making clinical audit data transparent

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

What information is being made available?

National Diabetes Transition Audit data for 2011-17 is available at England and Wales, Clinical Commissioning Group (CCG), Local Health Board (LHB) and Specialist Diabetes Service level for:

• Participation
• Patient demographics
• Prevalence
• Diabetes characteristics

Using and interpreting the data

Data from the National Diabetes Insulin Pump Audit should not be looked at in isolation when assessing standards of care.

Accessing the data

The data are being made available on the data.gov website. Local Health Boards and Specialist Diabetes Services are identified by name and organisation code.

What does the data cover?

The audit looks at the following areas:

• Care processes
• Treatment targets
• Structured Education
• Paediatric Services
• Adult Services
• Service Moves

What period does the data cover?

This data covers the top level findings from the 2011-17 National Diabetes Transition Audit for the period 1 April 2011 to 31 March 2017. This National Report was published on 10 January 2019.

The information available from this webpage comes from the National Diabetes Inpatient Audit. The National Diabetes Inpatient Audit is a snapshot audit of diabetes inpatient care.

During September 2019, hospitals across England collected data on the characteristics of the hospital, including participation, staffing levels and care improvement initiatives. Wales did not participate in NaDIA 2019.

Making clinical audit data transparent

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

What information is being made available?

National Diabetes Inpatient Audit data for 2019 is available at hospital site level for:

• Audit participation and data completeness for the key fields
• Measures about the process of care given to patients
• Information about care outcomes and treatment.

These data do not list individual patient information nor do they contain any patient identifiable data.

Using and interpreting the data

Data from the National Diabetes Inpatient Audit should not be looked at in isolation when assessing standards of care.

Accessing the data

The data are being made available on the data.gov website. Each year a data file from the National Diabetes Inpatient Audit will be made available in CSV format. Hospitals are identified by name and their national code.

What period does the data cover?

This report covers hospital characteristics during September 2019. The audit report was published on 13 November 2020. Historic data is available for previous audit years (2010-2013, 2015-2017) where survey questions were comparable.

The information available from this webpage comes from the National Diabetes Inpatient Audit. The National Diabetes Inpatient Audit is a snapshot audit of diabetes inpatient care. During September 2019, hospitals across England collected data on the characteristics of the hospital, including participation, staffing levels and care improvement initiatives. Wales did not participate in NaDIA 2019. Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. What information is being made available? National Diabetes Inpatient Audit data for 2019 is available at hospital site level for: * Audit participation and data completeness for the key fields * Measures about the process of care given to patients * Information about care outcomes and treatment. These data do not list individual patient information nor do they contain any patient identifiable data. Using and interpreting the data Data from the National Diabetes Inpatient Audit should not be looked at in isolation when assessing standards of care. Accessing the data The data are being made available on the data.gov website. Each year a data file from the National Diabetes Inpatient Audit will be made available in CSV format. Hospitals are identified by name and their national code. What period does the data cover? This report covers hospital characteristics during September 2019. The audit report was published on 13 November 2020. Historic data is available for previous audit years (2010-2013, 2015-2017) where survey questions were comparable.

Making clinical audit data transparent

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

The National Diabetes Foot Care Audit (NDFA) is a continuous audit of diabetic foot disease in England and Wales. The audit enables all diabetes foot care services to measure their performance against NICE clinical guidelines and peer units, and to monitor adverse outcomes for people with diabetes who develop diabetic foot disease.

What information is being made available? 

Trust, service, sustainability and transformation partnership (STP), and clinical commissioning group (CCG) audit participation and data completeness for the key fields

Measures about the process of care given to patients 

Information about care outcomes and treatment.

These data do not list individual patient information nor do they contain any patient identifiable data.

Using and interpreting the data

Data from the National Diabetes Foot Care Audit should not be looked at in isolation when assessing standards of care.

Accessing the data

The data are being made available on the data.gov website. Each year a data file from the National Diabetes Foot Care Audit will be made available in CSV format. Trusts and CCGs are identified by name and national code. Foot care services and STPs are identified by name and locally derived code.

What does the data cover?

The audit looks at the following areas:

Structures: are the nationally recommended care structures in place for the management of diabetic foot disease?

Processes: does the treatment of active diabetic foot disease comply with nationally recommended guidance?

Outcomes: are the outcomes of diabetic foot disease optimised?

What period does the data cover?

This data covers patients first seen with a diabetic foot ulcer by a specialist foot team between 14 July 2014 and 31 March 2017. This National Report was published on 14 March 2018.

The Adolescent and Young Adult Type 1 Diabetes Audit (AYA; previously referred to as the National Diabetes Transition Audit, NDTA) links datasets from the adult and paediatric national diabetes audits. The AYA has been designed to audit care provision during the period when young people with diabetes move from paediatric to adult based clinical care. The audit covers the period 01 January 2017 to 31 March 2023 and the cohort consists of people with type 1 diabetes aged between 16 and 25 years old during the AYA period. The National Diabetes Audit (NDA) provides a comprehensive view of diabetes care in England and Wales. It measures the effectiveness of diabetes healthcare against National Institute for Health and Care Excellence (NICE) Clinical Guidelines and NICE Quality Standards*,**. The National Paediatric Diabetes Audit (NPDA) was established to compare the care and outcomes of all children and young people with diabetes receiving care from Paediatric Diabetes Units (PDUs) in England and Wales. -* NICE Clinical Guidelines – NG17: Type 1 diabetes in adults: diagnosis and management http://www.nice.org.uk/guidance/ng17 -** NICE – Diabetes in Adults Quality Standard https://www.nice.org.uk/guidance/qs208.

The NHS Diabetes Prevention Programme (NHS DPP) is a joint commitment from NHS England, Public Health England and Diabetes UK to deliver, at scale, evidence based behavioural interventions that can prevent or delay the onset of Type 2 diabetes in adults who have been identified as having non-diabetic hyperglycaemia. This report uses data collected alongside the National Diabetes Audit (NDA) for the period January 2017 to March 2018 inclusive. This report is for England only. Unlike the NDA, it does not include information on Wales.

Il National Diabetes Insulin Pump Audit fa parte del National Diabetes Audit (NDA).

Il National Diabetes Insulin Pump Audit raccoglie informazioni sul numero e le caratteristiche delle persone con diabete di tipo 1 utilizzando una pompa per insulina, i motivi per andare su una pompa per insulina e i risultati raggiunti da quando si avvia la pompa.

Rendere trasparenti i dati degli audit clinici

Nella sua lettera di trasparenza e dati aperti ai ministri del Consiglio dei ministri del 7 luglio 2011, il primo ministro si è impegnato a rendere disponibili i dati degli audit clinici provenienti dagli audit nazionali nell'ambito del programma nazionale di audit clinico e risultati dei pazienti.

Quali informazioni vengono messe a disposizione?

I dati del National Diabetes Insulin Pump Audit per il 2017-18 sono disponibili presso Inghilterra e Galles, Local Health Board (LHB) e Specialist Diabetes Service per:

• Partecipazione
  • Dati demografici dei pazienti
• Prevalenza
• Completamento del processo di cura
• Obiettivi di trattamento
• Caratteristiche del diabete

Utilizzo e interpretazione dei dati I dati del National Diabetes Insulin Pump Audit non devono essere considerati separatamente quando si valutano gli standard di cura.

Accesso ai dati I dati vengono resi disponibili sul sito data.gov.I consigli sanitari locali e i servizi specialistici per il diabete sono identificati dal codice dell'organizzazione.

Cosa coprono i dati? L'audit prende in esame i seguenti settori:

• Motivo per iniziare su una pompa di insulina
• Processi di cura
• Obiettivi di trattamento
• Educazione strutturata

Qual è il periodo coperto dai dati?

Questi dati coprono i risultati di alto livello del National Diabetes Insulin Pump Audit 2017-18 per il periodo dal 1 ° gennaio 2017 al 31 marzo 2018. La presente relazione nazionale è stata pubblicata l'8 agosto 2019.

The National Diabetes Audit (NDA) and the National Paediatric Diabetes Audit (NPDA) provide a comprehensive view of diabetes care in England and Wales. They measure the effectiveness of diabetes healthcare against National Institute for Health and Care Excellence (NICE) Clinical Guidelines and NICE Quality Standards. This is the second Young People with Type 2 Diabetes report (1). It aims to document the number of people with type 2 diabetes up to the age of 40 years, their patient characteristics and the diabetes care they receive. This is important because adverse diabetes and cardiovascular outcomes are more common in people who develop type 2 diabetes at an earlier age and it is thought the numbers of affected individuals are increasing (2,3).

What information is being made available?

Trust, service, and clinical commissioning group (CCG) audit participation and data completeness for the key fields

Making clinical audit data transparent

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

The National Diabetes Foot Care Audit (NDFA) is a continuous audit of diabetic foot disease in England and Wales. The audit enables all diabetes foot care services to measure their performance against NICE clinical guidelines and peer units, and to monitor adverse outcomes for people with diabetes who develop diabetic foot disease.

Measures about the process of care given to patients

Information about care outcomes and treatment.

These data do not list individual patient information nor do they contain any patient identifiable data.

Using and interpreting the data

Data from the National Diabetes Foot Care Audit should not be looked at in isolation when assessing standards of care.

Accessing the data

The data are being made available on the data.gov website. Each year a data file from the National Diabetes Foot Care Audit will be made available in CSV format. Trusts, CCGs and Networks are identified by name and their national code. Foot care services are identified by name and locally derived code.

What does the data cover?

The audit looks at the following areas:

• Structures: are the nationally recommended care structures in place for the management of diabetic foot disease?

• Processes: does the treatment of active diabetic foot disease comply with nationally recommended guidance?

• Outcomes: are the outcomes of diabetic foot disease optimised?

What period does the data cover?

This data covers patients first seen with a diabetic foot ulcer by a specialist foot team between 14 July 2014 and 8 April 2016. This National Report was published on 8 March 2017.